Better Context Better Decisions

Context counts in life sciences. The FENIX analyst team is tirelessly using its experience to put you in a position to succeed. Below, our readers without corporate access will find a wealth of contextualized life science insight ready to be purchased in the FENIX Marketplace. If our content sharing limitations are inconvenient for you, reach out to Brady for unlimited corporate, institutional, or individual access.

dexcom cover image
$599
Posted in: Glucose Monitoring May 01 | 2019Dexcom Q1 '19 Earnings UpdatePurchase Blast
tandem cover image
$599
Posted in: Insulin Delivery Apr 30 | 2019Tandem Q1 '19 Earnings UpdatePurchase Blast
merck and pfizer cover image
$599
Posted in: DPP-IVi, GLP-1RA, SGLT2i Apr 30 | 2019Merck and Pfizer Q1 '19 Earnings UpdatesPurchase Blast
lilly cover image
Free
Posted in: Basal Insulin, Bolus Insulin, DPP-IVi, Dual/triple agonist, GLP-1RA, Glucagon, Glucose Monitoring, Insulin Delivery, SGLT2i Apr 30 | 2019REWIND Filed; Empa T1DM, Nasal Glucagon Delayed; Lilly Q1 '19 Earnings UpdateAccess Free Blast
biocon cover image
$599
Posted in: Basal Insulin, Bolus Insulin Apr 26 | 2019Biocon CY Q1 '19 (FY Q4 '19) Earnings UpdatePurchase Blast
sanofi cover image
$599
Posted in: Basal Insulin, Bolus Insulin, Dual/triple agonist, GLP-1RA, GLP-1RA + Basal Apr 26 | 2019No Sotagliflozin CRL Clarity; Sanofi Q1 '19 Earnings UpdatePurchase Blast
lilly cover image
$599
Posted in: Glucagon Apr 22 | 2019No Lilly Nasal Glucagon Update?Purchase Blast
roche and abbott cover image
$599
Posted in: Glucose Monitoring Apr 17 | 2019Abbott and Roche Q1 '19 Earnings UpdatesPurchase Blast
JnJ cover image
$599
Posted in: SGLT2i Apr 16 | 2019JnJ Q1 '19 Earnings UpdatePurchase Blast
sanofi cover image
$599
Posted in: Basal Insulin, Bolus Insulin Apr 10 | 2019New Sanofi Insulin Savings ProgramPurchase Blast
$599
Posted in: Basal Insulin, Bolus Insulin, Other Apr 09 | 2019PBMs Take Center Stage at Third Senate Drug Pricing HearingPurchase Blast
1 66 67 68 69 70 88

Get the Latest Analysis

Stay informed and aligned with frequent updates to keep a pulse on the industry.

If you already have an account, please log in. If you have any questions or would like to subscribe to our services, please contact Brady.